ArticleOncotarget2015

Fasting cycles potentiate the efficacy of gemcitabine treatment in in vitro and in vivo pancreatic cancer models.

Martina D'Aronzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.